Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011570 (
depression
)
172,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present investigation reports on the use of problem solving therapy (PST) to treat
depression
in an 83-year-old woman with Parkinson's disease (PD) and concurrent mild cognitive impairment (MCI). A neuropsychological evaluation was conducted prior to the intervention and the patient demonstrated mild deficits of executive functioning and memory. The PST treatment consisted of 12 one-hour sessions that occurred weekly. Depressive symptoms were evaluated using the Hamilton
Depression
Rating scale and the Montgomery-Asberg
Depression
rating scale. At a post-treatment assessment (week 12), clinician assessment indicated that the client no longer met criteria for
MDD
. Weekly
depression
severity ratings showed significant reduction in severity of depressive symptoms over 12 weeks. Results at 1-month and 6-month follow-up demonstrated that the therapeutic gains were not only maintained, but that the client continued to improve. These results suggest that PST may be an effective treatment for the treatment of
depression
for individuals with a PD and concurrent MCI.
...
PMID:Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study. 1941 85
This paper presents a meta-analysis of studies examining prevalence of psychopathology among offspring of anxiety-disordered parents, with the purpose of determining overall risk among these offspring for developing anxiety and depressive disorders. Pooled odds ratios for these disorders among high-risk offspring, compared to offspring of psychiatric and non-psychiatric controls, were calculated. Sixteen papers (including three follow-up studies) were identified, encompassing 1892 offspring (ages 4-25 years). Results revealed that: (1) offspring of parents with anxiety disorders have greater risk for anxiety and depressive disorders than offspring of non-psychiatric controls (ORs=3.91 and 2.67, respectively) and greater risk for anxiety disorders than offspring of psychiatric controls (OR=1.84); (2) offspring of anxious parents have significantly greater odds of having each type of anxiety disorder and
MDD
compared to offspring of non-psychiatric controls (ORs range from 1.96 to 8.69); and (3) offspring of parents with anxiety only, anxiety plus
MDD
, and
MDD
only have similar odds of having anxiety and depressive disorders but significantly higher odds than offspring of parents without disorder. Results suggest that parental anxiety disorders confer significant risk for anxiety and
depression
in offspring. Additional studies are needed to examine whether there are differences among specific parental anxiety disorders.
...
PMID:Anxiety and depressive disorders in offspring at high risk for anxiety: a meta-analysis. 1970 50
This retrospective study assessed the correlations between various types of stressful life events (SLE) and suicidal adolescents and young adults with major depressive disorder (
MDD
;22), borderline personality disorder (BPD;18), and nonsuicidal adolescents and young adults with
MDD
(20) and BPD (20). A community control group of 40 participants was also evaluated. The measurements used were Life Events Checklist, Childhood Sexual Abuse Questionnaire, Suicide Risk Scale, and Beck
Depression
Inventory. Suicidal participants experienced a greater number of total lifetime negative events compared with nonsuicidal participants, irrespective of diagnosis, including a greater amount of negative life events in the year before the suicide attempt compared with the year before referral in the nonsuicidal group. Participants with
MDD
reported more lifetime negative events than participants with BPD. Suicidal adolescents did not have more lifetime death-related SLE than nonsuicidal adolescents, but
MDD
adolescents experienced more lifetime death-related SLE than BPD adolescents. Suicidal BPD participants reported more lifetime sex abuse-related SLE compared with nonsuicidal BPD participants. The complexity of the relationships between SLE and the interplay of both suicidality and underlying psychopathology is discussed with the relevant treatment implications.
...
PMID:A comparison of life events in suicidal and nonsuicidal adolescents and young adults with major depression and borderline personality disorder. 1984 May 86
Limited evidence suggests that
depression
is associated with poorer outcomes in behavioral weight loss programs; however, people with major depression are typically excluded from weight loss intervention trials. This study examined the effect of
depression
on women's participation and weight loss in behavioral treatment. Non-treatment seeking obese women over 40 years of age with major depressive disorder (
MDD
, n = 65) and without
MDD
(n = 125) were recruited into a 26-session group intervention. Primary analyses compared participants' mean weight change from baseline to 6 and 12 months; at 6 months, women with
MDD
lost a mean of 3.8 kg vs 4.3 kg for women without
MDD
(t = 0.54, p = .59). At 12 months, women with
MDD
lost 3.0 kg and women without
MDD
lost 3.6 kg (t = 0.44, p =.66). Women who attended at least 12 treatment sessions lost more weight than women who attended fewer sessions, regardless of
depression
status (ie, there was no significant interaction between
depression
and session attendance). Results suggest that
depression
should not be an exclusion criterion for weight loss intervention programs.
...
PMID:Does depression reduce the effectiveness of behavioral weight loss treatment? 1993 59
In everyday life, we often estimate rather than know. It was the goal of this study to assess the effect of depressed mood on cognitive estimation in old age. Cognitive estimation was performed in 44 subjects with major depressive disorder (
MDD
; DSM-IV) and 48 age-matched healthy subjects (HS). Severity of depressive symptoms was rated with the Montgomery-Asberg
Depression
Rating Scale (MADRS, mean=18.6+/-S.D. 4.85). Estimation tasks comprised the dimensions length (coin diameter), weight (pile of paper), quantity (number of marbles in a glass jar), and time (estimation of time it takes for a marble to roll down a marble track both before and after having observed it). Other than the procedure followed in previous tests on cognitive estimation, the tasks were performed by observing objects rather than pictures thereof.
MDD
patients overestimated time (before and after observation) and underestimated quantity. Cognitive estimation was not correlated to measures of frontal functioning or semantic knowledge. We conclude that
MDD
patients in old age are impaired to some extent in cognitive estimation and in the ability to correct themselves, deficits that are likely to affect the performance of everyday activities.
...
PMID:Cognitive estimation in aged patients with major depressive disorder. 2006 66
The association between cognitive performance and general functioning in
depression
is controversial. The present study evaluated the association between cognitive dysfunction and major depressive disorder (
MDD
, N=70) as compared with age- and gender-matched healthy controls (n=206) and its relationship to general functioning (physical and mental health quality of life, activities of daily living, and employment status) in participants with current
MDD
(n=26) and those with previous
MDD
only (n=44). Participants were assessed clinically using the Mini International Neuropsychiatric Interview (M.I.N.I.) for the
depression
groups and the Diagnostic Interview for Psychoses (DIP-DM) for the control group. Measures to evaluate cognition and quality of lifes comprised the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), the Short Form-36 Health Survey Questionnaire, and the Activities/Instrumental Activities of Daily Living (ADL/IADL); employment status was also assessed in
MDD
. The results showed that a) while individuals with current
depression
had worse cognitive performance in all domains than healthy controls, those individuals with previous
depression
had lasting cognitive impairments in the domains of immediate memory and attention as compared with healthy controls; b) individuals with current
depression
had lower scores in the visuospatial/constructional and attention domains and the total score than individuals with previous
depression
; c) individuals in the
depression
group as a whole who were currently unemployed had significantly lower scores in all domains (except attention) of cognitive function; d) cognitive function was not related to either physical or mental quality of life or impairments of activities of daily living (ADL, IADL); e) that unemployment in previous
depression
was related to poor cognitive function similar to those with current
depression
. The results indicate that
MDD
may have detrimental and lasting effects on cognitive performance partly related to poorer general functioning.
...
PMID:The role of cognitive impairment in general functioning in major depression. 2013 70
Electroconvulsive therapy (ECT) has been successfully used in the treatment of
depression
, particularly when the illness is refractory to pharmacological therapy. A recent study has shown that ECT is also effective in reducing both depressive and posttraumatic stress disorder (PTSD) symptoms in patients with major depression (
MDD
) and co-occurring PTSD. This raises the possibility that ECT might be effective in the treatment of PTSD, a disease whose prevalence has increased substantially in recent years. A characteristic symptom of PTSD is an exaggerated reactivity to startling sounds (acoustic startle response; ASR). In the present study, we investigated the effects of electroconvulsive shocks (ECS) on the ASR, in a rat model of traumatic stress. The animals were subjected to a restraint/tailshock paradigm and then administered ECS. ASR measurements were obtained at several time points following ECS administration. Although ECS had no effect in control rats, it significantly exacerbated the already potentiated ASR in the stressed group. While ECT may prove to be an effective treatment for certain symptoms of co-occurring
MDD
/PTSD or PTSD alone, it may exacerbate heightened arousal associated with PTSD.
...
PMID:Electroconvulsive shocks exacerbate the heightened acoustic startle response in stressed rats. 2014 Dec 93
Depression
is considered an important risk factor in patients with cardiovascular disease (CVD). Although the biological mechanism is unknown, it has been suggested that hyperactivity of platelets may have an important role in the onset and evolution of cardiovascular damage. The goals of this study were to evaluate by transmission electron microscopy and immunohistochemistry the presence of ultra-structural variations in platelets from individuals with recent diagnosis of major depression disease (
MDD
, patients without previous anti-depressant treatment and from healthy control subjects.). Platelets from depressed patients had a greater proportion of dendritic forms compared with those obtained from control subjects. Morphological changes, such as dilation of open canalicular and dense tubular systems, platelet vacuolization, electrodense pattern of membranes, and a different immunolocalization of P-selectin were observed in the platelets from depressed patients compared with those isolated from healthy subjects. Our results revealed ultra-structural changes in platelets isolated from patients with
MDD
suggestive of enhanced platelet activation.
...
PMID:Ultrastructural changes and immunolocalization of P-selectin in platelets from patients with major depression. 2019 66
The quality of the depressive experience in borderline personality disorder has always been perceived to be different from the
depression
experienced in major depression (
MDD
). This paper reviews those observations and studies of the particular ways in which this borderline personality disorder (BPD)
depression
/dysphoria has been described in the literature and makes note of the fact the patients with BPD often score more highly on self-rated scales of
depression
than on corresponding observer-rated scales. Often patients with BPD without
MDD
score as highly on
depression
rating scales as BPD patients with
MDD
and as highly as patients with
MDD
without BPD. Clinician-rated scales and operationalized diagnostic interviews do not easily capture the distinction between the
depression
of BPD and the
depression
of
MDD
. A fuller appreciation of the BPD patient's object relations, i.e., the nature of the interpersonal relationships and the person's reactions and affects to and within those relationships holds the key to understanding the nature of the quality of the
depression
of BPD.
...
PMID:The quality of depression in borderline personality disorder and the diagnostic process. 2020 97
OBJECTIVES: Research and theory provide initial support for the potential utility in distinguishing between recurrent and single episode
MDD
smokers for cessation treatment. However, no study to date has examined differences in clinical presentation at the outset of treatment among these two groups and whether these clinical profiles are indicative of early cessation failure (smoking on quit day). METHODS: In a secondary analysis of a sample of 179 smokers entering cessation treatment, we examined baseline differences in dysfunctional attitudes, maladaptive coping, self-efficacy to manage negative affect, depressive symptoms, depressed mood, and experienced pleasure from life events between smokers with a history of recurrent major depression (
MDD
-R; 54.7%) and single episode major depression (
MDD
-S). RESULTS: Results showed that
MDD
-R smokers reported lower self-efficacy to cope with negative affect, greater depressive symptoms, and greater depressed mood than
MDD
-S smokers, although no differences were found on dysfunctional attitudes, avoidance coping, and level of experienced pleasure from daily life events. A greater number of
MDD
-R compared to
MDD
-S smokers were not abstinent on their quit day, however a history of recurrent
MDD
did not increase risk for early cessation failure. CONCLUSIONS: The findings indicate that although depressed mood, negative affect-regulation ability, and
depression
severity distinguish recurrent and single episode
MDD
smokers at the start of cessation treatment, these differences do not necessarily portend greater risk for cessation failure in the early stages of treatment.
...
PMID:History of single episode and recurrent major depressive disorder among smokers in cessation treatment: Associations with depressive symptomatology and early cessation failure. 2022 75
<< Previous
1
2
3
4
5
6
7
8
9
10